Background:
Tumor mutation burden (TMB) has been reported to emerge as an independent biomarker of response to identify patients who would achieve benefit from immune checkpoint inhibitors. However, it still remains controversy that whether TMB can be a robust biomarker of response to programmed death-1 (PD-1)/programmed death-ligand 1 (PD-L1) inhibition. We performed this meta-analysis to assess the relationship between TMB and the efficacy with PD-1/PD-L1 inhibition in advanced nonsmall cell lung cancer (NSCLC).
Methods:
Following the recommendations of the PRISMA statement, electronic databases literature search was done on the published articles till March 2021, including Pubmed, Embase, and Cochrane library databases. Studies were selected that focused on comparing the efficacy of TMB-high group and TMB-low group in NSCLC patients received with immune checkpoint inhibitors. Meta-analysis Revman 5.3 software was utilized to calculate the pooled outcomes.
Results:
A systematic literature search was conducted 8 articles, including 11 comparative articles. Findings of our studies shown that patients with TMB-high group was associated with better clinical outcomes than TMB-low group, including progression-free survival (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.29–0.49; P < .00001), complete response (OR, 4.71; 95% CI, 2.32–9.57; P < .0001), durable clinical benefit (OR, 3.76; 95% CI, 2.38–5.96; P < .00001) and the objective response rate (OR, 3.14; 95% CI, 1.83–5.37; P < .0001). While, it failed to predict overall survival benefits (OR, 0.74; 95% CI, 0.45–1.20; P = .22).
Conclusions:
Our study found that NSCLC with high TMB who benefit from immunotherapy. The findings suggest that TMB could associated with a greater predictive power of response. Possibly a more TMB-oriented prediction model might gain more benefits from PD-1/PD-L1 inhibitors.
In order to explore the effect of the energetic complex on the thermal decomposition HMX, two new rare-earth energetic complexes [La(tza)(NO3)2(H2O)4]n (1) and [Ce(tza)(NO3)2(H2O)4]n (2) (Htza = tetrazole-1-acetic acid) were prepared by a solvent evaporation method. The obtained products were structurally characterized by Fourier-transform infrared spectroscopy (FTIR), elemental analysis, powder X-ray diffraction (PXRD), single crystal X-ray diffraction (XRD), and thermogravimetric analysis coupled with differential scanning calorimetry (TG-DSC). In addition, the compatibility of complex 1 with cyclotetramethylene tetranitramine (HMX) was studied by DSC and FTIR, respectively. Structural analysis suggested that complex 1 exhibits an orthorhombic, P 21 21 21 space group, and the La (III) ion was 10-fold coordinated in a distorted double-capped antiprism configuration. Complex 2 featured a one-dimensional, right-handed helical infinite chain. The effect of complexes 1 and 2 on the thermal decomposition of HMX was investigated by DSC, which revealed that complex 1 showed a slightly better effect than 2 on the thermal decomposition of HMX and released more heat. Furthermore, complex 1 had good compatibility with HMX, indicating that it may act as a combustion promoter for nitrate ester plasticized polyether (NEPE) solid propellant.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.